Pub Date : 2026-02-01Epub Date: 2025-09-05DOI: 10.1016/j.arcmed.2025.103303
Sofía Bernal-Vega , Gabriela Cruz-Carrillo , Orlando Flores-Maldonado , Miguel Becerril-García , Juan Carlos Corona-Castillo , Alberto Camacho-Morales
Background
Long-chain ceramides have been implicated in anxiety-like behavior and in priming microglial activation, suggesting a possible lipid–immune crosstalk in emotional regulation.
Methods
We systemically administered a mixture of C16:0, C18:0, C22:0, C24:0, and C24:1 ceramides to adult male and female mice. Anxiety-like behavior was assessed with behavioral tests. Microglial phenotypes in the cortex, hippocampus, and striatum were evaluated via flow cytometry. Regression models examined associations between behavior and immune markers. In vitro assays assessed phagocytosis, gene expression, mitochondrial potential, and ROS production in microglia after ceramide exposure.
Results
Female, but not male, mice showed anxiety-like behavior after ceramide treatment. CD86+ microglia increased in the cortex, while CD206+ microglia decreased across brain regions. Behavioral scores correlated with CD86+ cells in cortex and CD206+ cells in hippocampus. In vitro, ceramides enhanced phagocytosis and induced NLRP3 and TNF-α expression. Ceramides also reduced mitochondrial potential and increased ROS in microglia.
Conclusions
Ceramide administration was associated with anxiety-like behavior in female mice, along with changes in microglial activation. These effects appear to be associated with mitochondrial dysfunction and oxidative stress, suggesting a lipid–immune interaction that could contribute to anxiety vulnerability.
{"title":"Long chain ceramides promote Anxiety-like behavior and microglia activation in female mice","authors":"Sofía Bernal-Vega , Gabriela Cruz-Carrillo , Orlando Flores-Maldonado , Miguel Becerril-García , Juan Carlos Corona-Castillo , Alberto Camacho-Morales","doi":"10.1016/j.arcmed.2025.103303","DOIUrl":"10.1016/j.arcmed.2025.103303","url":null,"abstract":"<div><h3>Background</h3><div>Long-chain ceramides have been implicated in anxiety-like behavior and in priming microglial activation, suggesting a possible lipid–immune crosstalk in emotional regulation.</div></div><div><h3>Methods</h3><div>We systemically administered a mixture of C16:0, C18:0, C22:0, C24:0, and C24:1 ceramides to adult male and female mice. Anxiety-like behavior was assessed with behavioral tests. Microglial phenotypes in the cortex, hippocampus, and striatum were evaluated via flow cytometry. Regression models examined associations between behavior and immune markers. <em>In vitro</em> assays assessed phagocytosis, gene expression, mitochondrial potential, and ROS production in microglia after ceramide exposure.</div></div><div><h3>Results</h3><div>Female, but not male, mice showed anxiety-like behavior after ceramide treatment. CD86+ microglia increased in the cortex, while CD206+ microglia decreased across brain regions. Behavioral scores correlated with CD86+ cells in cortex and CD206+ cells in hippocampus. <em>In vitro</em>, ceramides enhanced phagocytosis and induced NLRP3 and TNF-α expression. Ceramides also reduced mitochondrial potential and increased ROS in microglia.</div></div><div><h3>Conclusions</h3><div>Ceramide administration was associated with anxiety-like behavior in female mice, along with changes in microglial activation. These effects appear to be associated with mitochondrial dysfunction and oxidative stress, suggesting a lipid–immune interaction that could contribute to anxiety vulnerability.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 2","pages":"Article 103303"},"PeriodicalIF":3.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144997470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-09-05DOI: 10.1016/j.arcmed.2025.103298
XIAOYU LIU, YANG YANG, YUEHUA YAN
{"title":"Comment on: Evaluation of Multimorbidity Burden in Frailty Transitions in Costa Rican Older Adults Using Multistate Markov Models","authors":"XIAOYU LIU, YANG YANG, YUEHUA YAN","doi":"10.1016/j.arcmed.2025.103298","DOIUrl":"10.1016/j.arcmed.2025.103298","url":null,"abstract":"","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 2","pages":"Article 103298"},"PeriodicalIF":3.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144997471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-09-04DOI: 10.1016/j.arcmed.2025.103292
Abderrezak Khelfi , Amira Zitout , Housseyn Chekireb , Hadjar Touati , Sarah Oumatouk , Dana Alsayed Ahmad , Houyam Askoufes , Ayoub Rabhi , Randa Talhi , Mohamed Azzouz
Background
Bisphenols are emerging pollutants of health concern. Exposure to bisphenols may impact hormone physiology, particularly during pregnancy, when the body is more vulnerable to disruptions.
Objective
This study aimed to identify bisphenol exposure profiles in pregnant women and to explore associations between urinary levels of these compounds and disruptions in reproductive and thyroid hormone levels during pregnancy.
Methods
This study was conducted on 384 pregnant women. After gathering the necessary information through a questionnaire, blood and urine samples were collected. Reproductive and thyroid hormones were measured by electrochemiluminescence, and bisphenols were detected by Liquid-chromatography tandem mass spectrometry (LC-MS/MS).
Results
BPA, BPS, and BPF were detected in 95.3, 76.3, and 73.9% of the analyzed samples, respectively. The mean concentrations were 6.689, 1.135, and 1.013 µg/g of creatinine for BPA, BPS, and BPF, respectively. A significant positive association was found between plasma levels of estradiol and urinary concentrations of bisphenols, as well as between plasma levels of progesterone and prolactin and urinary concentrations of BPA. Disruption of testosterone levels was associated with elevated BPS concentrations. Besides, no significant association was found between urinary bisphenol concentrations and thyroid hormone levels. Regarding exposure sources, a significant association was observed between the use of fake nails and high urinary BPA concentrations.
Conclusion
In this study, bisphenols were associated with altered levels of certain reproductive hormones during pregnancy. These changes could have adverse effects on maternal health and child development.
{"title":"Exposure Profiles to Bisphenols and Their Impact on Reproductive and Thyroid Hormones in Pregnant Women","authors":"Abderrezak Khelfi , Amira Zitout , Housseyn Chekireb , Hadjar Touati , Sarah Oumatouk , Dana Alsayed Ahmad , Houyam Askoufes , Ayoub Rabhi , Randa Talhi , Mohamed Azzouz","doi":"10.1016/j.arcmed.2025.103292","DOIUrl":"10.1016/j.arcmed.2025.103292","url":null,"abstract":"<div><h3>Background</h3><div>Bisphenols are emerging pollutants of health concern. Exposure to bisphenols may impact hormone physiology, particularly during pregnancy, when the body is more vulnerable to disruptions.</div></div><div><h3>Objective</h3><div>This study aimed to identify bisphenol exposure profiles in pregnant women and to explore associations between urinary levels of these compounds and disruptions in reproductive and thyroid hormone levels during pregnancy.</div></div><div><h3>Methods</h3><div>This study was conducted on 384 pregnant women. After gathering the necessary information through a questionnaire, blood and urine samples were collected. Reproductive and thyroid hormones were measured by electrochemiluminescence, and bisphenols were detected by Liquid-chromatography tandem mass spectrometry (LC-MS/MS).</div></div><div><h3>Results</h3><div>BPA, BPS, and BPF were detected in 95.3, 76.3, and 73.9% of the analyzed samples, respectively. The mean concentrations were 6.689, 1.135, and 1.013 µg/g of creatinine for BPA, BPS, and BPF, respectively. A significant positive association was found between plasma levels of estradiol and urinary concentrations of bisphenols, as well as between plasma levels of progesterone and prolactin and urinary concentrations of BPA. Disruption of testosterone levels was associated with elevated BPS concentrations. Besides, no significant association was found between urinary bisphenol concentrations and thyroid hormone levels. Regarding exposure sources, a significant association was observed between the use of fake nails and high urinary BPA concentrations.</div></div><div><h3>Conclusion</h3><div>In this study, bisphenols were associated with altered levels of certain reproductive hormones during pregnancy. These changes could have adverse effects on maternal health and child development.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 2","pages":"Article 103292"},"PeriodicalIF":3.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144989554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-09-04DOI: 10.1016/j.arcmed.2025.103291
Tongyong Yu , Meilan Chen , Beihui Huang, Junru Liu, Xiaozhe Li, Jingli Gu, Yanjuan Li, Juan Li
Objective
A subset of patients with multiple myeloma (MM) experience early relapse despite the absence of any high-risk features at diagnosis, defined as functional high-risk (FHR) MM with inferior prognosis. This study compared FHR and standard risk (SR) MM cohorts to investigate clinical risk factors and establish a validated prognostic model for early prediction of FHR in patients with MM that were transplanted.
Methods
A retrospective cohort study was conducted to analyze the clinical data of patients with MM. Univariate and multivariate analyses were performed to identify independent risk factors for FHR-MM. A prognostic nomogram was developed through logistic regression analysis and internally validated.
Results
The study cohort comprised 357 MM patients. Univariate and multivariate analyses identified the following as independent predictors of FHR-MM: lactate dehydrogenase (LDH) ≥190 U/L, PET-CT SUVmax ≥7.5 at baseline, post-induction ≥80% reduction in PET-CT SUVmax, platelet count <80×109/L, ferritin ≥650 µg/L, Pattern B of M-protein decline, and achieved complete remission (CR) after autologous stem cell transplantation (ASCT). The derived predictive model demonstrated area under the curve (AUC) scores of 0.753 (95% CI 0.666–0.840) for the training set and 0.857 (95% CI 0.759–0.954) for the validation set.
Conclusion
This study established a predictive nomogram for transplanted patients with FHR-MM that demonstrates robust discriminative capacity through internal validation.
目的:一部分多发性骨髓瘤(MM)患者在诊断时没有任何高危特征,但早期复发,定义为预后不良的功能性高风险(FHR) MM。本研究比较了FHR和标准风险(SR) MM队列,以探讨临床危险因素,并建立一个有效的预后模型,用于早期预测MM移植患者FHR的发生。方法采用回顾性队列研究对MM患者的临床资料进行分析,通过单因素和多因素分析确定FHR-MM的独立危险因素。通过逻辑回归分析和内部验证开发了预后nomogram。结果研究队列包括357例MM患者。单因素和多因素分析确定以下为FHR-MM的独立预测因素:乳酸脱氢酶(LDH)≥190 U/L,基线时PET-CT SUVmax≥7.5,诱导后PET-CT SUVmax降低≥80%,血小板计数和lt 80×109/L,铁蛋白≥650µg/L, m蛋白B型下降,自体干细胞移植(ASCT)后达到完全缓解(CR)。导出的预测模型显示,训练集的曲线下面积(AUC)得分为0.753 (95% CI 0.666-0.840),验证集的AUC得分为0.857 (95% CI 0.759-0.954)。结论本研究建立了FHR-MM移植患者的预测nomogram,该nomogram通过内部验证显示了稳健的判别能力。
{"title":"Clinical Feature and Predictive Model for Transplanted Patients With Functional High-Risk Multiple Myeloma","authors":"Tongyong Yu , Meilan Chen , Beihui Huang, Junru Liu, Xiaozhe Li, Jingli Gu, Yanjuan Li, Juan Li","doi":"10.1016/j.arcmed.2025.103291","DOIUrl":"10.1016/j.arcmed.2025.103291","url":null,"abstract":"<div><h3>Objective</h3><div>A subset of patients with multiple myeloma (MM) experience early relapse despite the absence of any high-risk features at diagnosis, defined as functional high-risk (FHR) MM with inferior prognosis. This study compared FHR and standard risk (SR) MM cohorts to investigate clinical risk factors and establish a validated prognostic model for early prediction of FHR in patients with MM that were transplanted.</div></div><div><h3>Methods</h3><div>A retrospective cohort study was conducted to analyze the clinical data of patients with MM. Univariate and multivariate analyses were performed to identify independent risk factors for FHR-MM. A prognostic nomogram was developed through logistic regression analysis and internally validated.</div></div><div><h3>Results</h3><div>The study cohort comprised 357 MM patients. Univariate and multivariate analyses identified the following as independent predictors of FHR-MM: lactate dehydrogenase (LDH) ≥190 U/L, PET-CT SUVmax ≥7.5 at baseline, post-induction ≥80% reduction in PET-CT SUVmax, platelet count <80×10<sup>9</sup>/L, ferritin ≥650 µg/L, Pattern B of M-protein decline, and achieved complete remission (CR) after autologous stem cell transplantation (ASCT). The derived predictive model demonstrated area under the curve (AUC) scores of 0.753 (95% CI 0.666–0.840) for the training set and 0.857 (95% CI 0.759–0.954) for the validation set.</div></div><div><h3>Conclusion</h3><div>This study established a predictive nomogram for transplanted patients with FHR-MM that demonstrates robust discriminative capacity through internal validation.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 2","pages":"Article 103291"},"PeriodicalIF":3.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144989646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study was designed to cross–sectionally evaluate the frequency of long COVID-19, along with their hematological and biochemical parameters in survivors of mild COVID-19 after 6–15 months of acute infection.
Methods
We recruited 75 age-matched healthy controls (HC) and 150 individuals who had recovered from mild cases of COVID-19. The recovered individuals were grouped according to the time elapsed since acute infection: 6–10 month (CoV_A) and >10–15 month of recovery (CoV_B). A brief clinical history was taken and detailed hematological and biochemical blood parameters were measured.
Results
In our study, 64% of individuals had symptoms of long COVID. There were differential symptoms and presenting complaints associated with time since acute infection. The recovered group had significantly different hemoglobin concentration, red blood cell (RBC) count, white blood cell (WBC) count, lymphocyte, interleukin-6 (IL-6), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and vitamin D3 levels, compared with the healthy controls (p<0.05). Differences were also found between the 6-10 months and the >10–15 month recovery groups (p<0.05).
Conclusion
Differential biochemical markers related to the time elapsed since acute infection show a different metabolic and biochemical status of the host at different time points after infection. Moreover, the pathophysiological pathways involved in these dysregulated biochemical markers should also be studied in relation to the long term impact of COVID-19 infection.
{"title":"Biochemical Profile of Recovered Individuals With Mild COVID-19: A Cross-Sectional View at Two Different Time Points","authors":"Uzair Abbas , Ishfaque Ahmed , Muhib Ullah Khalid , Sumbal Hafeez , Sawairah Mukhtiar , Niaz Hussain , Maryam Nasrumminallah , Muhammad Shahid Khan , Nisha Babar , Shizrah Ashraf , Pershad Kumar","doi":"10.1016/j.arcmed.2025.103286","DOIUrl":"10.1016/j.arcmed.2025.103286","url":null,"abstract":"<div><h3>Aim</h3><div>This study was designed to cross–sectionally evaluate the frequency of long COVID-19, along with their hematological and biochemical parameters in survivors of mild COVID-19 after 6–15 months of acute infection.</div></div><div><h3>Methods</h3><div>We recruited 75 age-matched healthy controls (HC) and 150 individuals who had recovered from mild cases of COVID-19. The recovered individuals were grouped according to the time elapsed since acute infection: 6–10 month (CoV_A) and >10–15 month of recovery (CoV_B). A brief clinical history was taken and detailed hematological and biochemical blood parameters were measured.</div></div><div><h3>Results</h3><div>In our study, 64% of individuals had symptoms of long COVID. There were differential symptoms and presenting complaints associated with time since acute infection. The recovered group had significantly different hemoglobin concentration, red blood cell (RBC) count, white blood cell (WBC) count, lymphocyte, interleukin-6 (IL-6), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and vitamin D3 levels, compared with the healthy controls (<em>p</em><0.05). Differences were also found between the 6-10 months and the >10–15 month recovery groups (<em>p</em><0.05).</div></div><div><h3>Conclusion</h3><div>Differential biochemical markers related to the time elapsed since acute infection show a different metabolic and biochemical status of the host at different time points after infection. Moreover, the pathophysiological pathways involved in these dysregulated biochemical markers should also be studied in relation to the long term impact of COVID-19 infection.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103286"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-08-20DOI: 10.1016/j.arcmed.2025.103268
Lívia da Cunha Agostini , Letícia Fernandes Dias Coelho , Renata Bárbara Machado e Silva , Nayara Nascimento Toledo Silva , Ana Cláudia Faria Lopes , Vanessa de Almeida Belo , Wendel Coura-Vital , Luiz Fernando de Medeiros Teixeira , Angélica Alves Lima , Glenda Nicioli da Silva
Background and Aims
The interaction between genetic polymorphisms and environmental factors increases the risk of developing a diabetic phenotype which is associated with systemic arterial hypertension (SAH) and cardiovascular diseases. Variants in the T-cell factor 7-like 2 (TCF7L2) gene have been associated with type 2 diabetes mellitus (T2DM). To investigate the association of the rs.11196205 polymorphism of the TCF7L2 gene with biochemical and anthropometric parameters and cardiovascular risk indices in Brazilian patients with SAH and T2DM.
Methods
The polymorphism was identified by qPCR in 664 samples from four groups: Control (CG-without diabetes or hypertension), diabetic (DG-normotensive), hypertensive (HG-without diabetes) and hypertensive diabetic (HDG), using the TaqMan® system. Biochemical dosages were taken for the lipid profile: triglycerides (TG), total cholesterol, HDL, LDL, and uric acid. Anthropometric measurements were taken for body mass index (BMI), visceral fat index and cardiovascular risk calculations, including the atherogenic index of plasma (AIP), visceral adiposity index (VAI), triglyceride-glucose (TyG) index and uric acid/HDL-c ratio (UA/HDL). Bivariate logistic regression was used to identify variables associated with SAH and T2DM. Subsequent categorical variables were analyzed using multinomial logistic regression.
Results
The GG genotype of the rs.11196205 variant of the TCF7L2 gene was associated with an increased risk of hypertension and diabetic hypertension. Patients in the GHD group with the GG genotype showed worsening BMI parameters and TyG index values.
Conclusion
The GG genotype of the rs.11196205 variant of the TCF7L2 gene acts as a cardiovascular risk genotype in patients with diabetic hypertension.
{"title":"rs.11196205 Variant in the TCF7L2 Gene is Associated With an Increased Cardiovascular Risk in Individuals With Hypertension and Diabetes","authors":"Lívia da Cunha Agostini , Letícia Fernandes Dias Coelho , Renata Bárbara Machado e Silva , Nayara Nascimento Toledo Silva , Ana Cláudia Faria Lopes , Vanessa de Almeida Belo , Wendel Coura-Vital , Luiz Fernando de Medeiros Teixeira , Angélica Alves Lima , Glenda Nicioli da Silva","doi":"10.1016/j.arcmed.2025.103268","DOIUrl":"10.1016/j.arcmed.2025.103268","url":null,"abstract":"<div><h3>Background and Aims</h3><div>The interaction between genetic polymorphisms and environmental factors increases the risk of developing a diabetic phenotype which is associated with systemic arterial hypertension (SAH) and cardiovascular diseases. Variants in the T-cell factor 7-like 2 (<em>TCF7L2</em>) gene have been associated with type 2 diabetes mellitus (T2DM). To investigate the association of the rs.11196205 polymorphism of the <em>TCF7L2</em> gene with biochemical and anthropometric parameters and cardiovascular risk indices in Brazilian patients with SAH and T2DM.</div></div><div><h3>Methods</h3><div>The polymorphism was identified by qPCR in 664 samples from four groups: Control (CG-without diabetes or hypertension), diabetic (DG-normotensive), hypertensive (HG-without diabetes) and hypertensive diabetic (HDG), using the TaqMan® system. Biochemical dosages were taken for the lipid profile: triglycerides (TG), total cholesterol, HDL, LDL, and uric acid. Anthropometric measurements were taken for body mass index (BMI), visceral fat index and cardiovascular risk calculations, including the atherogenic index of plasma (AIP), visceral adiposity index (VAI), triglyceride-glucose (TyG) index and uric acid/HDL-c ratio (UA/HDL). Bivariate logistic regression was used to identify variables associated with SAH and T2DM. Subsequent categorical variables were analyzed using multinomial logistic regression.</div></div><div><h3>Results</h3><div>The GG genotype of the rs.11196205 variant of the <em>TCF7L2</em> gene was associated with an increased risk of hypertension and diabetic hypertension. Patients in the GHD group with the GG genotype showed worsening BMI parameters and TyG index values.</div></div><div><h3>Conclusion</h3><div>The GG genotype of the rs.11196205 variant of the <em>TCF7L2</em> gene acts as a cardiovascular risk genotype in patients with diabetic hypertension.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103268"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Recently, the potential use of plasma serotonin concentration as a biomarker for various diseases has been reported. However, whether plasma serotonin levels are useful for diagnosing attention deficit hyperactivity disorder (ADHD) remains controversial. To evaluate 5-hydroxytryptamine (5-HT, serotonin) as a biomarker for ADHD diagnosis, its severity, and overweight/obesity in school-aged children.
Methods
Eighty-nine school-aged children (20 controls and 69 with ADHD: 17 hyperactive, 26 inattentive, and 26 mixed) were analyzed. Free 5-HT (5-HTF) and platelet 5-HT (5-HTP) levels were compared for ADHD presence, severity, and obesity, respectively, using the Kruskal-Wallis test. Multiple regression models assessed the predictive value of 5-HTF and 5-HTP for the presence and severity of ADHD, adjusting for age and obesity. The diagnostic utility of 5-HTF was evaluated using odds ratios (OR) and area under the curve (AUC) from logistic regression.
Results
Patients with ADHD exhibited significantly elevated 5-HTF levels. No significant subgroup differences were found, but 5-HTF levels increased with ADHD severity. Higher 5-HTF levels were also observed in patients with overweight/obesity. Inverse trends were noted for 5-HTP, though less pronounced. Logistic regression showed a 71 % increase in ADHD odds for each 0.1 µmol/L rise in 5-HTF. ORs for ADHD severity were 8.77 (severe), 2.31 (moderate), and 0.45 (mild). The AUC for 5-HTF was 0.76 for ADHD diagnosis and 0.93 for moderate/severe ADHD.
Conclusions
Plasma 5-HTF concentration can be a useful biomarker for the ADHD diagnosis, its severity, and comorbidity with overweight/obesity in these patients.
{"title":"Plasma Serotonin as a Biomarker of the Severity of Attention Deficit Hyperactivity Disorder, in Children and Overweight/Obesity","authors":"Gabriel Manjarrez-Gutiérrez , Martha Cristina Fernández-Cruz , Chiharu Murata , Teresa Neri-Gómez","doi":"10.1016/j.arcmed.2025.103259","DOIUrl":"10.1016/j.arcmed.2025.103259","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Recently, the potential use of plasma serotonin concentration as a biomarker for various diseases has been reported. However, whether plasma serotonin levels are useful for diagnosing attention deficit hyperactivity disorder (ADHD) remains controversial. To evaluate 5-hydroxytryptamine (5-HT, serotonin) as a biomarker for ADHD diagnosis, its severity, and overweight/obesity in school-aged children.</div></div><div><h3>Methods</h3><div>Eighty-nine school-aged children (20 controls and 69 with ADHD: 17 hyperactive, 26 inattentive, and 26 mixed) were analyzed. Free 5-HT (5-HT<sub>F</sub>) and platelet 5-HT (5-HT<sub>P</sub>) levels were compared for ADHD presence, severity, and obesity, respectively, using the Kruskal-Wallis test. Multiple regression models assessed the predictive value of 5-HT<sub>F</sub> and 5-HT<sub>P</sub> for the presence and severity of ADHD, adjusting for age and obesity. The diagnostic utility of 5-HT<sub>F</sub> was evaluated using odds ratios (OR) and area under the curve (AUC) from logistic regression.</div></div><div><h3>Results</h3><div>Patients with ADHD exhibited significantly elevated 5-HT<sub>F</sub> levels. No significant subgroup differences were found, but 5-HT<sub>F</sub> levels increased with ADHD severity. Higher 5-HT<sub>F</sub> levels were also observed in patients with overweight/obesity. Inverse trends were noted for 5-HT<sub>P</sub>, though less pronounced. Logistic regression showed a 71 % increase in ADHD odds for each 0.1 µmol/L rise in 5-HT<sub>F</sub>. ORs for ADHD severity were 8.77 (severe), 2.31 (moderate), and 0.45 (mild). The AUC for 5-HT<sub>F</sub> was 0.76 for ADHD diagnosis and 0.93 for moderate/severe ADHD.</div></div><div><h3>Conclusions</h3><div>Plasma 5-HT<sub>F</sub> concentration can be a useful biomarker for the ADHD diagnosis, its severity, and comorbidity with overweight/obesity in these patients.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103259"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-08-27DOI: 10.1016/j.arcmed.2025.103285
Raymundo A. Muñoz Cabello , Luis A. Hernández Flores , Alfonzo E. Muñoz Cabello , Salvador Pizarro Chávez
Background
Colorectal cancer (CRC) is the third most prevalent cancer worldwide and the second leading cause of cancer-related deaths. Early-onset CRC is often more aggressive and is on the rise. In Mexico, 16,082 cases were diagnosed in 2022; however, epidemiological data remain limited—especially in northern regions where red meat consumption is high and screening adherence is low. This study aims to identify regional CRC trends in Chihuahua, a northeastern Mexican state.
Methods
A retrospective cohort study of CRC cases from 2018 to 2023 was conducted at two centers in Chihuahua City. Data on demographics, tumor location, stage, and genetic testing (KRAS, NRAS, and BRAF) were obtained from medical and pathology records. Analysis included descriptive statistics, t-tests and χ2 tests (p≤0.05), and a moving average analysis to assess annual trends.
Results
Among 451 CRC cases, the mean age was 60 ± 12 years and 57.8% were male. Two-thirds presented with advanced-stage disease (III/IV). Patients ≤49 years showed a high prevalence of proximal tumors and advanced-stage diagnoses, especially stage IVc. Over half of metastatic cases lacked genetic analysis. There was a U-shaped trend among age groups, with patients under 50 and over 70 being diagnosed at higher clinical stages (p=0.6).
Conclusions
The high proportion of advanced-stage CRC in patients under 50, combined with the lack of genetic testing, highlights two key issues in our region: aggressive disease and limited access to adequate care. These findings underscore the need for targeted research and improved public health strategies in high-risk areas such as northern Mexico.
{"title":"A Pattern of Increased Aggressiveness for Colorectal Cancer in Northern Mexico: A Multicenter Retrospective Cohort From 2018 to 2023","authors":"Raymundo A. Muñoz Cabello , Luis A. Hernández Flores , Alfonzo E. Muñoz Cabello , Salvador Pizarro Chávez","doi":"10.1016/j.arcmed.2025.103285","DOIUrl":"10.1016/j.arcmed.2025.103285","url":null,"abstract":"<div><h3>Background</h3><div>Colorectal cancer (CRC) is the third most prevalent cancer worldwide and the second leading cause of cancer-related deaths. Early-onset CRC is often more aggressive and is on the rise. In Mexico, 16,082 cases were diagnosed in 2022; however, epidemiological data remain limited—especially in northern regions where red meat consumption is high and screening adherence is low. This study aims to identify regional CRC trends in Chihuahua, a northeastern Mexican state.</div></div><div><h3>Methods</h3><div>A retrospective cohort study of CRC cases from 2018 to 2023 was conducted at two centers in Chihuahua City. Data on demographics, tumor location, stage, and genetic testing (KRAS, NRAS, and BRAF) were obtained from medical and pathology records. Analysis included descriptive statistics, <em>t</em>-tests and χ<sup>2</sup> tests (<em>p</em>≤0.05), and a moving average analysis to assess annual trends.</div></div><div><h3>Results</h3><div>Among 451 CRC cases, the mean age was 60 ± 12 years and 57.8% were male. Two-thirds presented with advanced-stage disease (III/IV). Patients ≤49 years showed a high prevalence of proximal tumors and advanced-stage diagnoses, especially stage IVc. Over half of metastatic cases lacked genetic analysis. There was a <em>U</em>-shaped trend among age groups, with patients under 50 and over 70 being diagnosed at higher clinical stages (<em>p</em>=0.6).</div></div><div><h3>Conclusions</h3><div>The high proportion of advanced-stage CRC in patients under 50, combined with the lack of genetic testing, highlights two key issues in our region: aggressive disease and limited access to adequate care. These findings underscore the need for targeted research and improved public health strategies in high-risk areas such as northern Mexico.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103285"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144902203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rheumatoid arthritis (RA) can lead to disability and premature death. Knowledge of the RA burden is necessary for strategic healthcare management, resource allocation, and preventive measures. The burden of RA was analyzed with projected rates for 2030 and 2040.
Methods
Incidence, prevalence, mortality, and burden of suffering from RA were analyzed using the most recent Global Burden of Disease (GBD) dataset for RA from 1990 to 2019. Predictive estimates were calculated using the SPSS Time Series Modeler.
Results
In 2019, approximately 530,000 individuals had RA (64.0 % were female, and 35.9 % were between 15 and 49 years old). The age-standardized prevalence (ASP) and incidence (ASI) rates were 427.6 and 25.4 cases per 100,000 people, respectively. The Mexican states with the highest ASP, disability-adjusted life years (DALY), and years of healthy life lost due to disability rates were Oaxaca, Tlaxcala, and Zacatecas. The national ASP and ASI rates of RA are projected to increase to 465.5 and 27.9 by 2030, and to 518.9 and 30.2 per 100,000 inhabitants by 2040, respectively. In contrast, age-standardized mortality and DALY rates are projected to decline to 1.2 and 77.8 in 2030 and 1.1 and 73.6 per 100,000 inhabitants in 2040, respectively.
Conclusions
The burden of RA, especially the burden of disability continues to increase. Despite substantial investments in clinical care, research, and public health initiatives, the rate of increase shows no signs of abating. Certain regions of Mexico, such as Oaxaca, Tlaxcala, and Zacatecas, have a disproportionately high burden.
背景与目的类风湿性关节炎(RA)可导致残疾和过早死亡。了解RA负担对于战略性医疗保健管理、资源分配和预防措施是必要的。对RA的负担进行了分析,并预测了2030年和2040年的发病率。方法使用最新的全球疾病负担(GBD)数据集分析1990年至2019年RA的发病率、患病率、死亡率和患者负担。使用SPSS Time Series Modeler计算预测估计。结果2019年,约53万人患有RA,其中女性占64.0%,年龄在15 - 49岁之间的占35.9%。年龄标准化患病率(ASP)和发病率(ASI)分别为每10万人427.6例和25.4例。ASP、残疾调整生命年(DALY)和因残疾率而损失的健康生命年数最高的墨西哥州是瓦哈卡州、特拉斯卡拉州和萨卡特卡斯州。到2030年,全国平均年龄和平均年龄的RA比率预计将分别增加到465.5和27.9,到2040年将分别增加到每10万居民518.9和30.2。相比之下,预计到2030年,年龄标准化死亡率和DALY死亡率将分别降至每10万居民1.2人和77.8人,2040年降至每10万居民1.1人和73.6人。结论RA负担,尤其是致残负担持续加重。尽管在临床护理、研究和公共卫生倡议方面进行了大量投资,但增长率没有显示出减弱的迹象。墨西哥的某些地区,如瓦哈卡州、特拉斯卡拉州和萨卡特卡斯州,有不成比例的高负担。
{"title":"Projections of the Burden of Rheumatoid Arthritis in Mexico from 2020 to 2040","authors":"Claudia Mendoza-Pinto , Pamela Munguía-Realpozo , Ivet Etchegaray-Morales , Roberto Berra-Romani , Edith Ramírez-Lara , Socorro Méndez-Martínez , Alvaro José Montiel-Jarquín , Gabriela Medina-Valeriano , Jorge Ayón-Aguilar","doi":"10.1016/j.arcmed.2025.103270","DOIUrl":"10.1016/j.arcmed.2025.103270","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Rheumatoid arthritis (RA) can lead to disability and premature death. Knowledge of the RA burden is necessary for strategic healthcare management, resource allocation, and preventive measures. The burden of RA was analyzed with projected rates for 2030 and 2040.</div></div><div><h3>Methods</h3><div>Incidence, prevalence, mortality, and burden of suffering from RA were analyzed using the most recent Global Burden of Disease (GBD) dataset for RA from 1990 to 2019. Predictive estimates were calculated using the SPSS Time Series Modeler.</div></div><div><h3>Results</h3><div>In 2019, approximately 530,000 individuals had RA (64.0 % were female, and 35.9 % were between 15 and 49 years old). The age-standardized prevalence (ASP) and incidence (ASI) rates were 427.6 and 25.4 cases per 100,000 people, respectively. The Mexican states with the highest ASP, disability-adjusted life years (DALY), and years of healthy life lost due to disability rates were Oaxaca, Tlaxcala, and Zacatecas. The national ASP and ASI rates of RA are projected to increase to 465.5 and 27.9 by 2030, and to 518.9 and 30.2 per 100,000 inhabitants by 2040, respectively. In contrast, age-standardized mortality and DALY rates are projected to decline to 1.2 and 77.8 in 2030 and 1.1 and 73.6 per 100,000 inhabitants in 2040, respectively.</div></div><div><h3>Conclusions</h3><div>The burden of RA, especially the burden of disability continues to increase. Despite substantial investments in clinical care, research, and public health initiatives, the rate of increase shows no signs of abating. Certain regions of Mexico, such as Oaxaca, Tlaxcala, and Zacatecas, have a disproportionately high burden.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103270"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-08-20DOI: 10.1016/j.arcmed.2025.103269
Griselda-Adriana Cruz-Priego , Miguel Ángel Guagnelli , Sergio Ortiz Santiago , Karina Geraldine González Castelan , Rita A. Gomez-Diaz , Ludovic Humbert , Patricia Clark
Background and Aims
This study evaluates three-dimensional dual-energy X-ray absorptiometry (3D-DXA) parameters that determine the cortical and trabecular compartments in patients with type 2 diabetes (T2D) compared to nondiabetic subjects, with the aim of identifying their determinants.
Methods
Patients with T2D were diagnosed according to ADA criteria. Anthropometric measurements were taken, and body mass index (BMI) was calculated. Bone densitometry (DXA) images were analyzed with 3D Shaper software. Volumetric bone mineral density (vBMD), bone mineral content (BMC), and volume were calculated in various regions of the femur, along with cortical thickness. Data analysis was performed using SPSS 27.0, a Student t-test and ANCOVA.
Results
A total of 125 subjects were recruited: 51 healthy controls and 74 patients with T2D (70.3 % women), with an average age of 53.9 and 53.6 years, respectively. The average disease duration in the T2D group was 11.4 years. Significant vitamin D deficiencies (levels <20 ng/mL) were found in 56 % of the control group and in 64 % of the T2D group. No significant differences in aBMD were observed between the two groups. 3D-DXA analysis showed consistently lower vBMD in patients with T2D vs. controls, with significant differences in the trochanter, femoral neck, and average cortical thickness. A positive correlation was observed between waist circumference, BMI, and higher bone density in all regions.
Conclusions
This study demonstrates the potential of 3D-DXA to detect cortical and trabecular bone differences in patients with T2D, undetectable by aBMD. Women with T2D showed lower bone parameters in the trochanter and femoral neck, consistent with research linking long-term T2D and poor glycemic control to compromised bone quality.
{"title":"Comparative Analysis of Cortical and Trabecular Bone Structure Between Patients With Type 2 Diabetes and Healthy Controls","authors":"Griselda-Adriana Cruz-Priego , Miguel Ángel Guagnelli , Sergio Ortiz Santiago , Karina Geraldine González Castelan , Rita A. Gomez-Diaz , Ludovic Humbert , Patricia Clark","doi":"10.1016/j.arcmed.2025.103269","DOIUrl":"10.1016/j.arcmed.2025.103269","url":null,"abstract":"<div><h3>Background and Aims</h3><div>This study evaluates three-dimensional dual-energy X-ray absorptiometry (3D-DXA) parameters that determine the cortical and trabecular compartments in patients with type 2 diabetes (T2D) compared to nondiabetic subjects, with the aim of identifying their determinants.</div></div><div><h3>Methods</h3><div>Patients with T2D were diagnosed according to ADA criteria. Anthropometric measurements were taken, and body mass index (BMI) was calculated. Bone densitometry (DXA) images were analyzed with 3D Shaper software. Volumetric bone mineral density (vBMD), bone mineral content (BMC), and volume were calculated in various regions of the femur, along with cortical thickness. Data analysis was performed using SPSS 27.0, a Student <em>t</em>-test and ANCOVA.</div></div><div><h3>Results</h3><div>A total of 125 subjects were recruited: 51 healthy controls and 74 patients with T2D (70.3 % women), with an average age of 53.9 and 53.6 years, respectively. The average disease duration in the T2D group was 11.4 years. Significant vitamin D deficiencies (levels <20 ng/mL) were found in 56 % of the control group and in 64 % of the T2D group. No significant differences in aBMD were observed between the two groups. 3D-DXA analysis showed consistently lower vBMD in patients with T2D vs. controls, with significant differences in the trochanter, femoral neck, and average cortical thickness. A positive correlation was observed between waist circumference, BMI, and higher bone density in all regions.</div></div><div><h3>Conclusions</h3><div>This study demonstrates the potential of 3D-DXA to detect cortical and trabecular bone differences in patients with T2D, undetectable by aBMD. Women with T2D showed lower bone parameters in the trochanter and femoral neck, consistent with research linking long-term T2D and poor glycemic control to compromised bone quality.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103269"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}